{"disease":{"id":"breast-density","name":"breast density"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03920098","title":"Chilean Maternal & Infant Cohort Study II (CHiMINCs-II)","phase":"","overall_status":"UNKNOWN","enrollment_count":1927,"lead_sponsor_name":"Instituto de Nutrición y Tecnología de los Alimentos","has_results":false},{"nct_id":"NCT04535466","title":"Diagnosis Predictive Modle for Dense Density Breast Tissue Based on Radiomics","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","has_results":false},{"nct_id":"NCT03029286","title":"ENGAGED 2 Study: Experiences With Mammography Screening and Breast Density 2","phase":"NA","overall_status":"COMPLETED","enrollment_count":995,"lead_sponsor_name":"Georgetown University","has_results":true},{"nct_id":"NCT02986360","title":"Informed Implementation of Breast Density Reporting","phase":"NA","overall_status":"COMPLETED","enrollment_count":500,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT00089661","title":"AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":252,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT05068388","title":"Effect of Oral (Z)-Endoxifen in Premenopausal Women With Measurable Breast Density","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":240,"lead_sponsor_name":"Atossa Therapeutics, Inc.","has_results":false},{"nct_id":"NCT03199963","title":"Trial of 4-Hydroxytamoxifen (4-OHT) Gel in Women Aimed at Reducing Dense Breast Tissue","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":223,"lead_sponsor_name":"BHR Pharma, LLC","has_results":true},{"nct_id":"NCT04498013","title":"Study of the Effects of Cyclodynon on Reducing the Cumulative Risk of Breast Cancer Development in a Female Aged 40-52","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Dr. Struk Tetiana","has_results":false},{"nct_id":"NCT04616430","title":"Topical Endoxifen in Women","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"Atossa Therapeutics, Inc.","has_results":true},{"nct_id":"NCT07434128","title":"Mammogram Pretreatment With Ulipristal Acetate","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":26,"lead_sponsor_name":"OHSU Knight Cancer Institute","has_results":false},{"nct_id":"NCT05181059","title":"DLSCT for Breast Cancer Detection in Women With Dense Breasts","phase":"","overall_status":"UNKNOWN","enrollment_count":14,"lead_sponsor_name":"Rijnstate Hospital","has_results":false},{"nct_id":"NCT03629717","title":"RANKL Inhibition and Breast Tissue Biomarkers","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Washington University School of Medicine","has_results":false}],"total":12},"guidelines":[],"source":"Drug Landscape verified database"}